The total value of the global amniotic products market was USD 810.4 million in 2022, and it will rise at a growth rate of above 8.7% shortly, reaching USD 1,451.2 million by 2030.
The growth of the industry is ascribed to the continuing research to enlarge the application area, utilization of these products for the treatment of eye and skin illnesses, and increasing prevalence of traumatic wounds and injuries because of burns, as well as the rising consciousness about the usage of amniotic products for their treatment.
The growth in the count of individuals with burns is a major contributor to the market development. This is because of the increasing requirement for amniotic membranes because of the high occurrence of burn wounds.
Furthermore, these accidents lead to considerable physical and emotional damage which ultimately fuels the market. With nearly 9 million wounds and a projected 120,000–180,000 demises per annum, these wounds place a substantial load on the worldwide population. Most of these fires take place in emerging and developing countries, with over two thirds occurring in Africa and Southeast Asia.
In the recent years, North America dominated the sector, with a revenue share of more than 60%. The key contributors to the regional industry development are the existence of key market competitors and deep-rooted healthcare amenities. During the forecast period, the growing attention being given to substitute technologies is projected to further boost the sector’s development in the region.
Hence, the amniotic products market is propelled by the wide research being carried out in this area and the growing occurrence of burns and surgical injuries.
No comments:
Post a Comment